CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (vol 72, pg 962, 2017)

著录项

• 来源
  《European urology》 |2018年第4期|共3页
• 作者

  Escudier Bernard; Sharma Padmanee; McDermott David F.; George Saby; Hammers Hans J.; Srinivas Sandhya; Tykodi Scott S.; Sosman Jeffrey A.; Procopio Giuseppe; Plimack Elizabeth R.; Castellano Daniel; Gurney Howard; Donskov Frede; Peltola Katriina; Wagstaff John; Gauler Thomas C.; Ueda Takeshi; Zhao Huanyu; Waxman Ian M.; Motzer Robert J.;

  展开▼
• 作者单位

  Inst Gustave Roussy Villejuif France;

  Univ Texas MD Anderson Canc Ctr Boston MA USA;

  Dana Farber Harvard Canc Ctr Beth Israel Deaconess Med Ctr Boston MA USA;

  Roswell Pk Canc Inst Buffalo NY 14263 USA;

  Johns Hopkins Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;

  Stanford Canc Inst Stanford CA USA;

  Univ Washington Seattle WA 98195 USA;

  Vanderbilt Univ Ctr Med Nashville TN 37232 USA;

  Fdn Inst Nazl Tumori Milan Italy;

  Fox Chase Canc Ctr 7701 Burholme Ave Philadelphia PA 19111 USA;

  Hosp Univ 12 Octubre Madrid Spain;

  Westmead Hosp Westmead NSW Australia;

  Aarhus Univ Hosp Aarhus Denmark;

  Univ Helsinki Cent Hosp Canc Ctr Comprehens Canc Ctr Helsinki Finland;

  South West Wales Canc Inst Swansea W Glam Wales;

  Univ Duisburg Essen Univ Hosp Essen Germany;

  Chiba Canc Ctr Chiba Japan;

  Bristol Myers Squibb Princeton NJ USA;

  Bristol Myers Squibb Princeton NJ USA;

  Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 泌尿科学（泌尿生殖系疾病）;
• 关键词